Skip to main content

Table 2 Outcome Measures

From: Physio4FMD: protocol for a multicentre randomised controlled trial of specialist physiotherapy for functional motor disorder

Assessment

Domain of measurement

Timing

T0

T1

T2

Physical Function domain, SF36 [21]

Physical disability

X

X

X

Short Form 36 (SF36) [20]

Health related quality of life

X

X

X

Functional Mobility Scale [22]

Mobility related disability

X

X

X

Revised Illness Perception Questionnaire [23]

Illness belief and understanding

X

X

X

Hospital Anxiety and Depression Scale [24]

Anxiety and Depression

X

X

X

Clinical Global Impression Scale of Improvement (CGI-I) [25]

Patient perception of change

 

X

X

Fatigue (5-point scale) [26]

Fatigue

X

X

X

EQ-5D-5 L [27]

Health Economics, to generate QALYS

X

X

X

Client Service Receipt Inventory (CSRI) [28]

Health Economics, health resource use

X

X

X

Work Productivity & Activity Impairment Questionnaire (WPAI) [29]

Employment and return to work

X

X

X

Confidence in correctness of diagnosis of FMD (10 point scale) [30]

Illness belief, confidence in diagnosis

X

X

X

Extended Patient Health Questionnaire-15 (PHQ-15) [31, 32]

Somatic symptom severity

X

  

Hospital Episode Statistics (HES)

Health Economics, health resource use

X

 

X

  1. Abbreviations: T0 Baseline assessment, T1 6-month assessment, T2 12-month assessment, QALYS Quality Adjusted Life Years. Pain is assessed as part of the SF36 and EQ-5D-5L questionnaires